Palonosetron hydrochloride
Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) . It is the most effective of the 5-HT3 antagonists in controlling delayed CINV nausea and vomiting that appear more than 24 hours after the first dose of a course of chemotherapy and is the only drug of its class approved for this use by the U.S. Food and Drug Administration. As of 2008, it is the most recent 5-HT3 antagonist to enter clinical use.
Product Specifications
CAS Number
135729-62-3
Product Name Alternative
Aloxi | RS 25259-197
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
Water: 67 mg/mL (201.27 mM)
Smiles
C1C[C@@H]2CN (C (=O) C3=C2C (=CC=C3) C1) [C@@H]4CN5CCC4CC5.Cl
Molecular Formula
C19H24N2O·HCl
Molecular Weight
332.87
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Colloidal Gold Conjugated Monoclonal Antibody to Human IgM CH6, 5nm
Human IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IGHD/2730R), CF405S conjugate, 0.1mg/mL
